跳至主要内容
临床试验/NCT03386136
NCT03386136已完成1 期

Therapeutic Oxygen for Gastrointestinal Atony (TOGA): Pilot Trial - Management of Acute Colonic Pseudo-Obstruction With Oxygen Supplementation

University of Florida1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2018年1月25日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
17
试验地点
1
主要终点
Changes in Diameter of Colon

研究概览

简要总结

This study is a non invasive study to see if 100% oxygen therapy will help to resolve an intestinal obstruction.

详细描述

TOGA involves the provision of a 6- hour treatment with 100% oxygen via non breather mask to hospitalized patients with ileus, small bowel obstruction and/or colonic pseudo-obstruction will be a useful supplemental therapy, decreasing the diameter of the intestinal lumen and enhancing resolution of ileus/pseudo-obstruction

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 100 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient or health proxy has been adequately informed of risks and benefits and agrees to his/her participation in the study.
  • patient is a hospitalized inpatient diagnosed with ileus, bowel obstruction or colonic pseudo-obstruction [clinician interpretation or small bowel diameter ≥3.5 cm, cecal diameter ≥ 9 cm, sigmoid colon diameter ≥ 6 cm].
  • patient is clinically and hemodynamically stable
  • patient does not require supplemental oxygen greater than 2 liters per minute via nasal cannula
  • patient does not have any respiratory contraindications to 100% oxygen
  • failure to respond to non-surgical/non-endoscopic therapy for at least 24 hours, therapy at discretion of treating physician [to eliminate patients with trivial ileus not requiring advanced intervention]

排除标准

  • patient is not expected to survive in the short term.
  • patient is a pregnant or lactating woman.
  • patient presents with severe or unstable psychiatric disorders.
  • patient is participating in concomitant research studies that would interfere with this study.
  • patient is an alcohol or drug abuser.
  • respirator support required.
  • unable to tolerate 100% oxygen for respiratory reasons or any other reasons.
  • perforation of the viscus.
  • inability to obtain informed consent.
  • hypoxemia, as in room air oxygen saturation less than 90%.

研究组 & 干预措施

Hospitalized Ileus or Pseudo-Obstruction Patient

Experimental

Hospitalized inpatient diagnosed with ileus, bowel obstruction or colonic pseudo-obstruction [clinician interpretation or small bowel diameter ≥3.5 cm, cecal diameter ≥ 9 cm, sigmoid colon diameter ≥ 6 cm] provided with 100% oxygen via non-rebreather face mask, for 6 hours

干预措施: 100% Oxygen (Drug)

结局指标

主要结局

Changes in Diameter of Colon

时间窗: 6 - 24 hours

X-ray of kidney, ureter and bladder (KUB) to determine maximal cecal diameter, maximal mid-transverse colon diameter, maximal mid-sigmoid colon diameter.

Changes in Diameter of the Small Bowel

时间窗: 6 - 24 hours

X-ray of kidney, ureter and bladder (KUB) to determine maximal cecal diameter, maximal mid-transverse colon diameter, maximal mid-sigmoid colon diameter.

次要结局

  • Patient Complaints(Up to 48 hours)
  • Demonstrates No Resolution of Ileus(24 - 30 hours after initial TOGA)
  • Worsening of Ileus(24 - 30 hours after initial TOGA)
  • Need for endoscopic or surgical intervention(24 - 30 hours after initial TOGA)
  • Length of Hospital Stay(up to 100 weeks)
  • Patient Pain Measurement(Up to 48 hours)
  • Medication Measurement(24 hours before through 24 hours after TOGA)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Therapeutic Oxygen for Gastrointestinal Atony (TOGA) | 临床试验